166 related articles for article (PubMed ID: 12689985)
21. Comparative assessment of enprofylline and theophylline for chronic obstructive airways disease in the elderly.
Arnold JD; Courtenay-Evans RJ; Whitfield R; O'Reilly JF; Petrie GR; Higgins AJ; Swift CG
Respir Med; 1990 May; 84(3):211-5. PubMed ID: 2218006
[TBL] [Abstract][Full Text] [Related]
22. Effect of theophylline on the rate of moderate to severe exacerbations among patients with chronic obstructive pulmonary disease.
Cyr MC; Beauchesne MF; Lemière C; Blais L
Br J Clin Pharmacol; 2008 Jan; 65(1):40-50. PubMed ID: 17764476
[TBL] [Abstract][Full Text] [Related]
23. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.
Troosters T; Celli B; Lystig T; Kesten S; Mehra S; Tashkin DP; Decramer M;
Eur Respir J; 2010 Jul; 36(1):65-73. PubMed ID: 20185426
[TBL] [Abstract][Full Text] [Related]
24. Theophylline for COPD.
Barnes PJ
Thorax; 2006 Sep; 61(9):742-4. PubMed ID: 16936233
[TBL] [Abstract][Full Text] [Related]
25. Better lungs for better legs: novel bronchodilator effects in COPD.
Calverley P
Thorax; 2010 Jul; 65(7):573-5. PubMed ID: 20627910
[No Abstract] [Full Text] [Related]
26. [Diagnosis and management of chronic obstructive pulmonary disease].
Sato N; Kanazawa M
Kyobu Geka; 2007 Aug; 60(9):841-8. PubMed ID: 17703625
[TBL] [Abstract][Full Text] [Related]
27. [Pathophysiological basis for using bronchodilatators in COPD].
Similowski T
Rev Pneumol Clin; 2002 Sep; 58(4 Pt 2):2S5-9. PubMed ID: 12458312
[No Abstract] [Full Text] [Related]
28. QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease.
van Noord JA; Buhl R; Laforce C; Martin C; Jones F; Dolker M; Overend T
Thorax; 2010 Dec; 65(12):1086-91. PubMed ID: 20978028
[TBL] [Abstract][Full Text] [Related]
29. The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.
Make B; Hanania NA; ZuWallack R; Kalberg C; Emmett A; Brown CP; Knobil K
Clin Ther; 2005 May; 27(5):531-42. PubMed ID: 15978302
[TBL] [Abstract][Full Text] [Related]
30. The role of bronchodilators in controlling COPD symptoms.
Raisbeck E
Community Nurse; 2000 Jun; 6(5):19-20. PubMed ID: 12778532
[No Abstract] [Full Text] [Related]
31. Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials.
Barr RG; Rowe BH; Camargo CA
BMJ; 2003 Sep; 327(7416):643. PubMed ID: 14500434
[TBL] [Abstract][Full Text] [Related]
32. Use of theophylline in chronic obstructive pulmonary disease: examining the evidence.
Ram FS
Curr Opin Pulm Med; 2006 Mar; 12(2):132-9. PubMed ID: 16456383
[TBL] [Abstract][Full Text] [Related]
33. Tiotropium-lessons from recent studies.
Black PN
Respirology; 2009 Jul; 14(5):623-4. PubMed ID: 19659644
[No Abstract] [Full Text] [Related]
34. Family increases: UPLIFT first maintenance subgroup analysis.
Puente-Maestú L; De Miguel J
Eur Respir J; 2010 Jul; 36(1):10-1. PubMed ID: 20595162
[No Abstract] [Full Text] [Related]
35. Comparison between theophylline and an adenosine non-blocking xanthine in acute asthma.
Vilsvik JS; Persson CG; Amundsen T; Brenna E; Naustdal T; Syvertsen U; Storstein L; Källén AG; Eriksson G; Holte S
Eur Respir J; 1990 Jan; 3(1):27-32. PubMed ID: 2311727
[TBL] [Abstract][Full Text] [Related]
36. Comparison of oral enprofylline and theophylline in asthmatic patients.
Laursen LC; Johannesson N; Søndergaard I; Weeke B
Eur J Clin Pharmacol; 1984; 26(6):707-9. PubMed ID: 6489410
[TBL] [Abstract][Full Text] [Related]
37. [Long-acting bronchodilator agents are the choice in COPD. Keeping the airways open continuously].
MMW Fortschr Med; 2007 Nov; 149(47):54. PubMed ID: 18064817
[No Abstract] [Full Text] [Related]
38. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Lee TA; Schumock GT; Bartle B; Pickard AS
Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
[TBL] [Abstract][Full Text] [Related]
39. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
[TBL] [Abstract][Full Text] [Related]
40. Inhaled corticosteroids for chronic obstructive pulmonary disease.
Park HY; Man SF; Sin DD
BMJ; 2012 Oct; 345():e6843. PubMed ID: 23100329
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
